CN102573612B - 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 - Google Patents

包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 Download PDF

Info

Publication number
CN102573612B
CN102573612B CN201080039021.4A CN201080039021A CN102573612B CN 102573612 B CN102573612 B CN 102573612B CN 201080039021 A CN201080039021 A CN 201080039021A CN 102573612 B CN102573612 B CN 102573612B
Authority
CN
China
Prior art keywords
dosage form
magnetic field
magnetic
particles
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080039021.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102573612A (zh
Inventor
B·哈特维希
N·温德哈布
M·莱夫克
J·托米尔卡尔德
M·达姆
R·利兹奥
M·戈特沙尔克
A·奥尔夫
C·枚尔
A·格里柯兹克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roma Chemical Co ltd
Evonik Operations GmbH
Original Assignee
Evonik Roehm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm GmbH filed Critical Evonik Roehm GmbH
Publication of CN102573612A publication Critical patent/CN102573612A/zh
Application granted granted Critical
Publication of CN102573612B publication Critical patent/CN102573612B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201080039021.4A 2009-09-03 2010-08-30 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 Expired - Fee Related CN102573612B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23961309P 2009-09-03 2009-09-03
US61/239,613 2009-09-03
DE102009029170.9 2009-09-03
DE102009029170 2009-09-03
PCT/EP2010/062641 WO2011026808A1 (en) 2009-09-03 2010-08-30 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles

Publications (2)

Publication Number Publication Date
CN102573612A CN102573612A (zh) 2012-07-11
CN102573612B true CN102573612B (zh) 2015-07-08

Family

ID=42984007

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080039021.4A Expired - Fee Related CN102573612B (zh) 2009-09-03 2010-08-30 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型

Country Status (13)

Country Link
US (1) US9050256B2 (https=)
EP (1) EP2473095B1 (https=)
JP (1) JP5868319B2 (https=)
KR (1) KR101731130B1 (https=)
CN (1) CN102573612B (https=)
BR (1) BR112012004967B8 (https=)
CA (1) CA2772708C (https=)
ES (1) ES2528494T3 (https=)
IL (1) IL217897A (https=)
MX (1) MX2012002677A (https=)
PL (1) PL2473095T3 (https=)
SI (1) SI2473095T1 (https=)
WO (1) WO2011026808A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140341983A1 (en) * 2011-09-14 2014-11-20 Donn M. Dennis Smart™ solid oral dosage forms
DE102011089334A1 (de) * 2011-12-21 2013-06-27 Evonik Röhm Gmbh Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus
US11667906B2 (en) * 2014-11-24 2023-06-06 Corning Incorporated Magnetic microcarriers
US11024449B2 (en) * 2017-06-06 2021-06-01 Apple Inc. Multipole elastomeric magnet with magnetic-field shunt
CA3084087A1 (en) 2017-12-04 2019-06-13 Evonik Operations Gmbh Masking and subsequently visualising esr signals using the combination of two materials
US10824822B2 (en) * 2019-02-05 2020-11-03 International Business Machines Corporation Magnetic tracking for medicine management
US10679018B1 (en) 2019-02-05 2020-06-09 International Business Machines Corporation Magnetic tracking for medicine management
JP7502741B2 (ja) * 2019-09-26 2024-06-19 スピンセンシングファクトリー株式会社 磁気マーカーおよび磁気マーカー検出システム
AU2021356684A1 (en) 2020-10-09 2023-05-11 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
CN112360304A (zh) * 2020-11-06 2021-02-12 炫丽建材江苏有限公司 一种适用于22度免拉手门板的自愈合封边工艺
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
JP2025512969A (ja) 2022-04-06 2025-04-22 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ｈｅｒ２陽性転移性乳がん及び他のがんを治療するための組成物及び方法
US20250250326A1 (en) 2022-04-06 2025-08-07 The Trustees Of The University Of Pennsylvania Passive immunization with anti-aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079006A (en) * 1987-07-15 1992-01-07 Aprex Corporation Pharmaceutical compositions containing a magnetically detectable material
CN1094577A (zh) * 1994-02-02 1994-11-09 湖南省商业科技研究所 磁疗食品及其制备方法
CN1785430A (zh) * 2005-10-25 2006-06-14 南京工业大学 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物
CN1909869A (zh) * 2004-01-22 2007-02-07 弗·哈夫曼-拉罗切有限公司 固体剂型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3740187A1 (de) 1987-11-27 1989-06-08 Urquhart John Verfahren und vorrichtung zum ueberwachen und/oder kontrollieren und/oder registrieren und/oder anzeigen der einnahme von pharmazeutischen praeparaten
DE3940260A1 (de) 1989-03-04 1990-09-13 Werner Weitschies Verfahren zur bestimmung des aufenthaltsortes und der bewegung von objekten durch ihre markierung als magnetisches moment
US6081734A (en) 1996-08-16 2000-06-27 Roche Diagnostics Gmbh Monitoring system for the regular intake of a medicament
JP2004331750A (ja) 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
EP1880716A1 (en) 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
DE102008033662A1 (de) 2008-07-11 2010-01-14 Technische Universität Ilmenau Pharmakologische Darreichungsform und Vorrichtung und Verfahren zur kontinuierlichen Lokalisierung und Verfolgung des Auflösevorganges dieser

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079006A (en) * 1987-07-15 1992-01-07 Aprex Corporation Pharmaceutical compositions containing a magnetically detectable material
CN1094577A (zh) * 1994-02-02 1994-11-09 湖南省商业科技研究所 磁疗食品及其制备方法
CN1909869A (zh) * 2004-01-22 2007-02-07 弗·哈夫曼-拉罗切有限公司 固体剂型
CN1785430A (zh) * 2005-10-25 2006-06-14 南京工业大学 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying》;W.Weitschies.eta;《European Journal of Pharmaceutics and Biopharmaceutics》;20081231(第70期);641-648 *
《Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms》;Werner Weitschies,eta;《Advanced Drug Delivery Reviews》;20051231(第57期);1210-1222 *
《Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract》;Werner Weitschies，eta;《European Journal of Pharmaceutics and Biopharmaceutics》;20101231(第74期);93-101 *

Also Published As

Publication number Publication date
JP2013503831A (ja) 2013-02-04
IL217897A0 (en) 2012-03-29
WO2011026808A1 (en) 2011-03-10
ES2528494T3 (es) 2015-02-10
JP5868319B2 (ja) 2016-02-24
EP2473095A1 (en) 2012-07-11
KR20120060210A (ko) 2012-06-11
US9050256B2 (en) 2015-06-09
US20120143039A1 (en) 2012-06-07
HK1168016A1 (en) 2012-12-21
BR112012004967A2 (pt) 2016-04-05
SI2473095T1 (sl) 2015-02-27
IL217897A (en) 2014-06-30
PL2473095T3 (pl) 2015-04-30
KR101731130B1 (ko) 2017-05-11
BR112012004967B1 (pt) 2021-05-11
CA2772708A1 (en) 2011-03-10
EP2473095B1 (en) 2014-11-12
CA2772708C (en) 2017-07-11
MX2012002677A (es) 2012-04-11
WO2011026808A8 (en) 2012-03-15
BR112012004967B8 (pt) 2022-07-05
CN102573612A (zh) 2012-07-11

Similar Documents

Publication Publication Date Title
CN102573612B (zh) 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型
US9696279B2 (en) Detection system for detecting magnetic objects in the human organism
Balamuralidhara et al. pH sensitive drug delivery systems: a review
McClean et al. Binding and uptake of biodegradable poly-DL-lactide micro-and nanoparticles in intestinal epithelia
Xing et al. Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome
US20190365645A1 (en) Drug delivery articles for gram-level dosing
US10165988B2 (en) Personalized detection system for detecting magnetic objects in the human organism
Vidawati et al. Study of human serum albumin-SPIONs loaded PLGA nanoparticles for protein delivery
Corá et al. Biomagnetic methods: Technologies applied to pharmaceutical research
HK1168016B (en) Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
Mahmoud et al. A Deployable 4D Printed, Mucoadhesive and Magnetically Guided Patch for Local Therapy of Gastric Cancer
Majumdar et al. Design and gamma scintigraphic evaluation of colon specific pectin-EC pellets of secnidazole prepared by powder layering technology
Arora et al. Radiopharmaceutical-based approaches for the determination of colon-targeting efficiency
Cora et al. Magnetic images with a biosusceptometer of pharmaceutical dosage forms in the human gastrointestinal tract
HK1199397B (en) Detection system for detecting magnetic objects in the human organism
Lanjhiyana et al. In-vitro and in-vivo release studies of methotrexate from novel enteric coated time-dependent microbial-triggered drug delivery systems for colon specific
TODOROV et al. A 2D nanosphere array for atomic

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1168016

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1168016

Country of ref document: HK

CP01 Change in the name or title of a patent holder

Address after: Essen, Germany

Patentee after: Evonik Operations Ltd.

Address before: Essen, Germany

Patentee before: EVONIK DEGUSSA GmbH

Address after: Darmstadt, Germany

Patentee after: Roma Chemical Co.,Ltd.

Address before: Darmstadt, Germany

Patentee before: EVONIK ROHM GmbH

CP01 Change in the name or title of a patent holder
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200619

Address after: Essen, Germany

Patentee after: EVONIK DEGUSSA GmbH

Address before: Darmstadt, Germany

Patentee before: Roma Chemical Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150708